Asensus Surgical, a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery (PGS), today announced that a leading United States-based hospital, has initiated a Senhance Surgical System program for use within their pediatric surgery department. The initiation of the Senhance program marks an important milestone as this represents the first system to be exclusively utilized by pediatric surgeons at a United States-based hospital, showcasing Senhance’s unique applicability for pediatric applications. We expect to provide further information in the next 60 days.
“We are thrilled to collaborate and introduce our Senhance Surgical System to this esteemed pediatric surgery program,” said Anthony Fernando, Asensus Surgical President, and CEO. “The collaboration highlights the shared commitment to innovation and patient-centric care. Together, we will strive to drive advancements in surgical techniques, ultimately improving the lives of children requiring surgery.”
The Senhance Surgical System, empowered by the Intelligent Surgical Unit™ (ISU™), represents a breakthrough in digital surgical platforms, leveraging augmented intelligence and machine learning for superior surgical performance and patient outcomes with features such as haptic feedback, eye-tracking camera control, and 3D visualization. Notably, its specialized 3mm instruments are perfectly suited for the delicate nature of pediatric procedures.
Source: Company Press Release
